# A Study in Healthy Male Volunteers to Test How the Test Medicine GLPG1972 is Taken up by the Body When Given by Mouth and Into the Vein as an Injection

> **NCT04136327** · PHASE1 · COMPLETED · sponsor: **Lakefront Biotherapeutics NV** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** GLPG1972 film-coated tablets
- **DRUG:** [14C]-GLPG1972 solution for infusion
- **DRUG:** [14C]-GLPG1972 oral solution

## Key facts

- **NCT ID:** NCT04136327
- **Lead sponsor:** Lakefront Biotherapeutics NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-13
- **Primary completion:** 2019-10-21
- **Final completion:** 2019-10-21
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04136327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04136327, "A Study in Healthy Male Volunteers to Test How the Test Medicine GLPG1972 is Taken up by the Body When Given by Mouth and Into the Vein as an Injection". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04136327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*